Phase III, Randomized, Double Blind Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients.
Phase of Trial: Phase III
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Colecalciferol (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Acronyms MelaViD
- 30 Jan 2018 Status changed from recruiting to discontinued.
- 02 Aug 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 02 Aug 2011 Actual initiation date change from Dec 2010 to May 2010 as reported by ClinicalTrials.gov.